Categories: News

NYSE Content Advisory: Annual International Day Slate Announced

NEW YORK, Sept. 18, 2025 /PRNewswire/ — The New York Stock Exchange will hold the 2nd annual NYSE International Day, on October 23, 2025, celebrating global business excellence and fostering cross-border innovation and investment. The event is designed to bring together C-suite executives of international innovators, PE/VC investors, and the NYSE listed community for a half-day of insightful discussions, networking, and product showcases, followed by a networking reception on the Trading Floor.

- Advertisement -

International companies from regions including Canada, UK/Europe, MEA, APAC and Latin America will showcase products and innovations during networking breaks. Scheduled sessions will include discussions on the future of fintech, scaling businesses beyond borders globally, future mobility innovations, exit strategies balancing M&A and IPOs, and bridging private and public markets for late-stage companies.

- Advertisement -

Announced speakers include:

- Advertisement -
  • Jim Cramer, CNBC host, who will deliver the Opening Keynote interview alongside NYSE President Lynn Martin
  • Scarlett Sieber, Chief Strategy & Growth Officer, Money20/20
  • Frederik Thomasen, Head of Equity Capital Markets, Norges Bank Investment Management (NBIM)
  • Anu Aiyengar, Managing Director, Global Head of Advisory and Mergers & Acquisitions, J.P. Morgan
  • Masaki (Mory) Morimoto, President, The House of Suntory
  • Wen Han, Founder, Chairman & CEO, Windrose Technology

Click here to REGISTER and learn more about NYSE International Day

- Advertisement -

Photo – https://mma.prnewswire.com/media/2774646/NYSE_Annual_International_Day_Slate_Announced.jpg

- Advertisement -

Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

Recent Posts

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: Context Therapeutics Inc. PHILADELPHIA, Jan. 16, 2026 (GLOBE…

2 hours ago

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE…

2 hours ago

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Company to host conference call and webcast on Tuesday, January 20, 2026 at 8:00 am…

2 hours ago

NeuroDyne Drops: Sharp Mind, Enhanced Memory, and Lasting Focus As Nature Intended, Ingredients

NEURODYNE DROPS INTRODUCED AS A COGNITIVE WELLNESS SUPPLEMENT SUPPORTING HEALTHY MEMORY, FOCUS, AND MENTAL CLARITY…

11 hours ago

Optivell Officially Announced as a Vision Support Formula for Preventive Eye Wellness

New York City, NY, Jan. 17, 2026 (GLOBE NEWSWIRE) -- OPTIVELL INTRODUCED AS A NEW…

11 hours ago

Sugar Clean Drops: Top Blood Sugar Support Supplement for Metabolic Wellness and Energy Support

SUGAR CLEAN DROPS ANNOUNCED AS A NEW SUPPLEMENT SUPPORTING HEALTHY BLOOD SUGAR AND METABOLIC WELLNESS…

11 hours ago